LEGNLegend Biotech Corporation

LEGN Stock Price, Valuation & Chart | Legend Biotech Corporation

Compare

$21.890+0.76 (+3.60%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology LEGN intrinsic value LEGN calculated fair value vs price

Overview Financials Dividends Ratios

LEGN Historical price chart

LEGN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization4.05B

PE Ratio-32.19

EPS-0.68

Trading Volume1.48M

Today's High/Low21.94/21.1

Dividend Yield0.00

52 Week High/Low37.5/16.24

Shares Outstanding184.94M

LEGN Financial Statement

LEGN Analyst ratings

LEGN Analysis & performance metrics

LEGN Company profile

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for…

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of…

LEGN Management team

Name

Position

Carlos SantosCFO

Chief Financial Officer

Alan S. Bash

President of CARVYKTI®

Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Tim Roberts

Global Compliance Officer

Elaine Qian

Vice President & Global Head of Human Resources

Guowei Fang Ph.D.

President of Research & Development

Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Name

Position

Carlos SantosCFO

Chief Financial Officer

Alan S. Bash

President of CARVYKTI®

Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Tim Roberts

Global Compliance Officer

Elaine Qian

Vice President & Global Head of Human Resources

Guowei Fang Ph.D.

President of Research & Development

Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Management Team

Carlos SantosCFO

Chief Financial Officer

Alan S. Bash

President of CARVYKTI®

Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Tim Roberts

Global Compliance Officer

Elaine Qian

Vice President & Global Head of Human Resources

Guowei Fang Ph.D.

President of Research & Development

Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Management

Carlos SantosCFO

Chief Financial Officer

Alan S. Bash

President of CARVYKTI®

Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Tim Roberts

Global Compliance Officer

Elaine Qian

Vice President & Global Head of Human Resources

Guowei Fang Ph.D.

President of Research & Development

Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Surabhi Verma

Manager of Investor Relations & Corporate Communications

Total 8 executives

LEGN Frequently asked questions

What is Legend Biotech Corporation (LEGN) Stock Price?

Current stock price of Legend Biotech Corporation (LEGN) stock is $21.890. The stock price is +3.60% higher in the session. The intraday range can be seen from this page. Volume of Legend Biotech Corporation (LEGN) stock is 1.48M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Legend Biotech Corporation (LEGN) stock price going up or down today?

The stock price of Legend Biotech Corporation (LEGN) can change with earnings, company news, and overall market sentiment. Legend Biotech Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Legend Biotech Corporation stock expensive at its current price?

Whether Legend Biotech Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LEGN on this page is -32.19. EPS on this page is -0.68. Compare those figures with peers and growth expectations before deciding if the current Legend Biotech Corporation price is justified.

How has the stock price of Legend Biotech Corporation (LEGN) performed historically?

Historical performance for Legend Biotech Corporation (LEGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LEGN reacted to past earnings and market events.

Should I buy Legend Biotech Corporation (LEGN) stock, at this price?

Buying Legend Biotech Corporation (LEGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.